Amphastar Pharma (AMPH) Tops Q3 EPS by 11c

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.14, $0.11 better than the analyst estimate of $0.03. Revenue for the quarter came in at $64.2 million versus the consensus estimate of $65.12 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• Goldman: 'Our top picks include XYZ, KLAR, AFRM, and CHYM'
• Oppenheimer Reiterates Perform Rating on D.R. Horton (DHI)
• Raymond James slaps Street-high $800 target on SpaceX, implying 440% upside